Cargando…
HbA1c Screening for Diabetes in Patients with Acute Coronary Syndrome: A Worthwhile Test or a Pitfall?
Background: Diagnostic concordance between HbA1c and other glucose-based tests is imperfect, and data on this problem in acute coronary syndrome (ACS) are still lacking. The aim of this study was to identify undiagnosed glucose abnormalities in ACS patients, and to compare the effectiveness and cons...
Autores principales: | Józwa, Robert, Bryśkiewicz, Marta, Safranow, Krzysztof, Majkowska, Liliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509534/ https://www.ncbi.nlm.nih.gov/pubmed/34640351 http://dx.doi.org/10.3390/jcm10194334 |
Ejemplares similares
-
HbA(1c) screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice?
por: Lugg, Sebastian T., et al.
Publicado: (2017) -
Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017) -
HbA(1c) for Diabetes Screening in Acute Coronary Syndrome: time for a reappraisal of the guidelines?
por: McCune, C, et al.
Publicado: (2015) -
Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore
por: Lim, Wei-Yen, et al.
Publicado: (2018) -
Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)